Our drug will target mitochondria – the powerhouse of the cell – to generate heat. This approach has been proven to fully reverse obesity and type 2 diabetes in animals. However, therapeutic application for humans was impossible, because mitochondrial heat production could only be induced by highly artificial methods with side effects. This changed after our recent breakthrough discovery of the protein that mitochondria naturally use to generate heat. We have developed a unique high-throughput drug discovery platform to identify compounds that selectively activate this target protein, without side effects. For decades people have wanted a drug that burns calories like exercise does. We are realizing this dream at Equator Therapeutics.
Company Details
- Employees
- 6
- Address
- San Francisco, Ca 94118, Us
- fo****@****ics.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- equatortherapeutics.com
- HQ
- San Francisco, CA
Equator Therapeutics Questions
Equator Therapeutics's website is equatortherapeutics.com
Equator Therapeutics's LinkedIn profile is https://www.linkedin.com/company/equator-therapeutics
Equator Therapeutics has
6 employees.
View email and phone details for 6
employees at Equator Therapeutics.
Equator Therapeutics's industry is
Biotechnology Research
Equator Therapeutics's top competitors are
Aeovian Pharmaceuticals,
Engage Bio,
Orsobio,
Levitree,
Flightpath Biosciences, Inc,
Tempero Bio,
Excepgen,
Sonalasense,
Samsara Therapeutics,
Immuneage Bio.
Equator Therapeutics's support email address is founders@equatortherapeutics.com
Equator Therapeutics's categories are Biotechnology Research
